Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Lactobacillus helveticus Rosell-52 and Reduced Depression Symptoms

Research synthesisLow evidenceModerate effect4 studies · 4 beneficial · 0 neutral · 0 harmful

Across 4 studies, all reported beneficial effects of Lactobacillus helveticus Rosell-52 on depression symptoms, with effect sizes ranging from small to moderate. A 2025 meta-analysis of 7 RCTs found a significant moderate-sized reduction in depressive symptoms (SMD -0.55, p=0.03). The evidence base is small and drawn primarily from reviews and meta-analyses including multi-strain probiotics, so the specific contribution of this single strain is not fully isolated.

  • Studied populations: adults with depression; adults with cancer

Caveats: Evidence base is small (only 4 studies) — conclusions should be considered preliminary. Available evidence is overwhelmingly positive — clinical literature in this area is subject to publication bias (null-result studies are less likely to be published or indexed). The highest-quality study (meta-analysis) reported high heterogeneity (I²=79%), indicating inconsistent effects across trials. Most data come from multi-strain probiotic interventions, making it difficult to attribute effects solely to Lactobacillus helveticus Rosell-52.

Generated Jun 11, 2026
4 of 4 papers
Back to top